Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome

The gut microbiota has an important role in the pathogenesis of hepatic encephalopathy(HE). Rifaximin, an intestinal non-absorbable antibacterial agent, is effective in the treatment of HE. However, whether long-term prophylactic use induces antibacterial resistance and its mechanism for treating HE...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xiao, Jin, Ye, Zhou, Wangxiao, Xiao, Tingting, Wu, Zhongwen, Su, Junwei, Gao, Hainv, Shen, Ping, Zheng, Beiwen, Luo, Qixia, Li, Lanjuan, Xiao, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804384/
https://www.ncbi.nlm.nih.gov/pubmed/35118004
http://dx.doi.org/10.3389/fcimb.2021.761192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804384/
https://www.ncbi.nlm.nih.gov/pubmed/35118004
http://dx.doi.org/10.3389/fcimb.2021.761192

Ejemplares similares